http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108472490-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3756 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37288 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-372 |
| filingDate | 2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108472490-B |
| titleOfInvention | Conducted communication in a medical device system |
| abstract | An implantable medical device for implantation within a patient may include: a housing; a pulse generating circuit at least partially disposed within the housing; a plurality of electrodes electrically coupled to the pulse generating circuit, the plurality of electrodes exposed outside of the housing; and a controller operatively coupled to the pulse generating circuit. The controller may be configured to command the pulse generation circuitry to deliver a phase conduction communication pulse via at least two of the plurality of electrodes. Additionally, the phase-conducted communication pulse may comprise a first phase having a first polarity followed by a second phase having a second, opposite polarity, wherein the second phase may have a duration of less than 60 microseconds, and wherein the first phase may have a duration of between 5% and 80% of the duration of said second phase. |
| priorityDate | 2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335491 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426099531 |
Total number of triples: 14.